Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms

Medicine and Dentistry

• Pioglitazone 100%
• Ramipril 83%
• Insulin Treatment 50%
• Forearm Blood Flow 50%
• Therapeutic Procedure 50%
• Plasma 50%
• Glucose 33%
• Vasodilatation 33%
• Fatty Acid 33%
• Maturity Onset Diabetes of the Young 33%
• Sodium Nitroprusside 33%
• Endothelin 1 33%
• Triacylglycerol 33%
• Blood Vessel Reactivity 33%
• Hyperaemia 33%
• Adiponectin 33%
• Acetylcholine 33%
• Glycemic Control 16%
• Research Design 16%
• Brachial Artery 16%
• Diabetes Mellitus 16%
• Insulin Resistance 16%
• Insulin Infusion 16%
• Intraarterial Drug Administration 16%
• Vasculitis 16%
• Plethysmography 16%
• Injection 16%
• Observation 16%
• Patient 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Pioglitazone 100%
• Ramipril 83%
• Nitroprusside Sodium 33%
• Non Insulin Dependent Diabetes Mellitus 33%
• Hyperemia 33%
• Triacylglycerol 33%
• Acetylcholine 33%
• Glucose 33%
• Fatty Acid 33%
• Endothelin 1 33%
• Adiponectin 33%
• Placebo 33%
• Insulin Resistance 16%
• Diabetes Mellitus 16%